NHS England Adds At-Home HPV Tests for Missed Screenings

NHS England is expanding its Cervical Screening Programme with at-home HPV testing for women who are not up to date. The rollout will target women aged 30 to 65 who have not accepted NHS invitations for in-person screenings. Participants receive a swab-based at-home test and free return postage to the NHS, where samples are screened for high-risk HPV.

Reach and Targets

The programme aims to reach 4 million women who are behind on screening. While up to 93 % of cervical cancer cases are preventable, only about two-thirds of eligible women in the UK regularly attend NHS screenings, below the programme’s 80 % target. The initiative builds on a 2021 YouScreen trial from NHS England and King’s College London, which found that at-home collection could boost total screenings across the UK by 400 000 women annually.

International Context

The UK rollout follows similar moves in the US. Following FDA approval, Teal Health’s self-collection kits are available nationwide, as a partner study with UC Davis aims to validate the use of at-home HPV self-collection in clinical workflows. The NHS continues to recommend in-person screenings, but the offering of at-home collection will target millions of women who have missed appointments due to HPV miseducation, scheduling conflicts, or medical anxiety.

Future Goals

The initiative’s broader goal is to eliminate cervical cancer by 2040. According to FemTech Insider, the programme will also feed into the national stats database, providing a clearer picture of screening uptake. The trial’s success mirrors the growth seen in the fixtures section of NHS data, underscoring the potential of self-collection to increase participation.

The rollout will begin in the coming months, with kits mailed directly to eligible women. Participants will simply swab the inside of their vagina, place the sample in the provided envelope, and mail it back. The NHS will then process the sample for high-risk HPV, and results will be communicated through the usual NHS channels.

The NHS’s decision to add at-home testing reflects a broader trend toward patient-centred care. By removing barriers such as travel time and clinic anxiety, the programme hopes to bring screening rates closer to the 80 % target and reduce the incidence of cervical cancer across the country. The initiative’s concrete detail is that it will reach 4 million women, a number that matches the scale of the national stats database and underscores the ambition of the NHS’s cervical cancer prevention strategy.